CTD vs eCTD: Key Differences in Pharmaceutical Regulatory Submissions
CTD versus eCTD is a decision for pharmaceutical companies who are preparing regulatory submissions for new medicines and for products already on the market. Both CTD and eCTD help organise documentation for regulatory review yet they differ in how the information is submitted and how it is managed. Knowing the differences between CTD and eCTD lets companies choose the approach for the regulatory authority and the market they target. I think this knowledge is essential for any team handling submissions.
What Is CTD?
CTD, which stands for Common Technical Document is a format used to organise pharmaceutical regulatory information. CTD has five modules: information, summaries, quality data, nonclinical studies and clinical studies. CTD brings harmony to dossier structure across regulatory regions making the documentation more consistent and easier to review.
What Is eCTD?
eCTD, short for Common Technical Document is the electronic version of the CTD format. ECTD uses an electronic submission system to organise documents manage submission sequences and support lifecycle updates. Depending on specifications eCTD submissions can improve document traceability and simplify the management of regulatory information.
CTD vs eCTD: Key Differences
Submission format: CTD usually refers to the dossier format whereas eCTD presents the dossier electronically using defined technical specifications.
Document management: Paper-based CTD submissions can require handling while eCTD supports electronic document organisation and tracking.
Lifecycle management: Updating CTD dossiers may mean replacing or resubmitting documents manually. ECTD supports sequences for amendments, variations and other regulatory updates.
Requirements: The accepted submission format depends on the regulatory authority, the product type and the regional guidelines, in place.
Which Format Should Pharmaceutical Companies Choose?
Choosing between CTD and eCTD depends on the target market and the submission requirements. Companies should check regulatory guidelines before preparing their dossiers so they stay compliant and avoid avoidable delays.
Conclusion
Understanding CTD versus eCTD helps pharmaceutical companies improve submission planning, documentation management and compliance. A well-organised dossier makes the regulatory review process more efficient and supports product lifecycle management.